The pronounced anti-senescent activity of E6AP indicates that – besides targeting the HPV oncogenes – blocking E6AP expression could provide a novel strategy to efficiently inhibit the growth of HPV-positive cancer cells. This evidence concerns the gene UBE3A and cancer.